Finance

Lists
Why is SBS down 4.07%?
Dive Deeper
SBS:FRA
Stratec SE
€ 21.20
-4.07%
(-0.90) 1D
10-р сарын 2, 08:01:26 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
€ 21.20
High
€ 21.20
Low
€ 21.20
Mkt. cap
262.89 сая
Avg. vol.
46.00
Volume
0.00
Dividend
2.83%
Quarterly dividend
€ 0.15
Ex-dividend date
2026 оны 6-р сарын 24
52-wk high
€ 32.20
52-wk low
€ 16.38
EPS
-€ 0.03
Shares outstanding
11.96 сая
No. of employees
1 мян.
Open
€ 21.20
High
€ 21.20
Low
€ 21.20
Mkt. cap
262.89 сая
Avg. vol.
46.00
Volume
0.00
Dividend
2.83%
Quarterly dividend
€ 0.15
Ex-dividend date
2026 оны 6-р сарын 24
52-wk high
€ 32.20
52-wk low
€ 16.38
EPS
-€ 0.03
Shares outstanding
11.96 сая
No. of employees
1 мян.
News stories
From web sources and news partners
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees1.38 мян
Founded1979
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
57.00 сая
75.28 сая
53.43 сая
59.11 сая
Cost of goods sold
43.70 сая
56.31 сая
43.22 сая
43.87 сая
Cost of revenue
43.70 сая
56.31 сая
43.22 сая
43.87 сая
Research and development expenses
1.59 сая
2.78 сая
1.72 сая
1.49 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.47 сая
10.82 сая
8.82 сая
9.64 сая
Operating expense
9.78 сая
11.19 сая
10.30 сая
9.66 сая
Total operating expenses
53.48 сая
67.50 сая
53.53 сая
53.54 сая
Operating income
3.52 сая
7.78 сая
-104.00 мян
5.57 сая
Other non operating income
-117.00 мян
219.00 мян
-65.00 мян
61.00 мян
EBT including unusual items
2.38 сая
-826.00 мян
-1.16 сая
5.43 сая
EBT excluding unusual items
2.38 сая
5.55 сая
-1.16 сая
5.43 сая
Income tax expense
878.00 мян
3.52 сая
557.00 мян
1.27 сая
Effective tax rate
36.91%
-426.03%
-48.18%
23.35%
Other operating expenses
-274.00 мян
-2.41 сая
-235.00 мян
-1.46 сая
Net income
1.50 сая
-4.34 сая
-1.71 сая
4.16 сая
Net profit margin
2.63%
-5.77%
-3.21%
7.04%
Earnings per share
-
-
-
-
Interest and investment income
33.00 мян
8.00 мян
34.00 мян
55.00 мян
Interest expense
-1.06 сая
-955.00 мян
-1.02 сая
-260.00 мян
Net interest expenses
-1.02 сая
-947.00 мян
-987.00 мян
-205.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
8.04 сая
10.71 сая
4.45 сая
10.03 сая
Gain or loss from assets sale
13.00 мян
3.00 мян
-94.00 мян
-9.00 мян
AI content may include mistakes. Learn more
Google аппс